PubMed laboratory research record [PMID: 42402644] PubMed record related to this compound for laboratory literature review
This is likely due to the more established CKD-specific evidence base available for SGLT2is [10,11,12], and the fact that FLOW evaluated semaglutide in patients receiving prior guideline-directed standard of care, limiting generalisability to GLP-1 RAs more broadly as a first-line therapy [8, 9]
3-MP is produced from L-Cys by cysteine aminotransferase (CAT) with -ketoglutarate as a coenzyme
The Increasing Prevalence of Chronic Lymphocytic Thyroiditis in Papillary Microcarcinoma
Analysis of protein adduction kinetics by quantitative mass spectrometry: competing adduction reactions of glutathione-S-transferase P1-1 with electrophiles
Together, these companies control the majority of the GLP-1 market and have become favourites among investors